Original Article

You have full text access to this OnlineOpen article

Evolution of autoimmune hepatitis to primary sclerosing cholangitis: A sequential syndrome

  1. Ayman A. Abdo1,
  2. Vincent G. Bain2,
  3. Krikor Kichian2,
  4. Samuel S. Lee M.D.1,*

Article first published online: 7 MAR 2007

DOI: 10.1002/hep.1840360615

Issue

Hepatology

Hepatology

Volume 36, Issue 6, pages 1393–1399, December 2002

Additional Information

How to Cite

Abdo, A. A., Bain, V. G., Kichian, K. and Lee, S. S. (2002), Evolution of autoimmune hepatitis to primary sclerosing cholangitis: A sequential syndrome. Hepatology, 36: 1393–1399. doi: 10.1002/hep.1840360615

Author Information

  1. 1

    Liver Unit, Division of Gastroenterology, University of Calgary, Calgary, Alberta

  2. 2

    Liver Unit, Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada

*Liver Unit, Division of Gastroenterology, University of Calgary, 3330 Hospital Dr. NW, Calgary, Alberta, T2N 4N1 Canada. fax: 403–270–0995

Publication History

  1. Issue published online: 7 MAR 2007
  2. Article first published online: 7 MAR 2007
  3. Manuscript Accepted: 21 SEP 2002
  4. Manuscript Received: 23 JUL 2002

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (743K)

Reference

  • 1
    Gregorio GV, Portmann B, Karani J, Harrison P, Donaldson PT, Vergani D, Mieli-Vergani G. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 2001; 33: 544–553.
    Direct Link:
  • 2
    Koskinas J, Raptis I, Manika Z, Hadziyannis S. Overlapping syndrome of autoimmune hepatitis and primary sclerosing cholangitis associated with pyoderma gangrenosum and ulcerative colitis. Eur J Gastroenterol Hepatol 1999; 11: 1421–1424.
  • 3
    Gohlke F, Lohse AW, Dienes HP, Lohr H, Marker-Hermann E, Gerken G, Meyer zum Buschenfelde KH. Evidence of an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J Hepatol 1996; 24: 699–705.
  • 4
    McNair AN, Moloney M, Portmann BC, Williams R, McFarlane IG. Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases. Am J Gastroenterol 1998; 93: 777–784.
    Direct Link:
  • 5
    Luketic V, Gomez D, Sanyal A, Shiffman M. An atypical presentation for primary sclerosing cholangitis. Dig Dis Sci 1997; 42: 2009–2016.
  • 6
    Ben-Ari Z, Dhillon AP, Sherlock S. Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis. Hepatology 1993; 18: 10–15.
    Direct Link:
  • 7
    Michieletti P, Wanless IR, Katz A, Scheuer PJ, Yeaman SJ, Bassendine MF, Heathcote J. Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. Gut 1994; 35: 260–265.
  • 8
    Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929–938.
  • 9
    Roberts EA. Primary sclerosing cholangitis in children. J Gastroenterol Hepatol 1999; 14: 588–593.
    Direct Link:
  • 10
    Czaja AJ. Variant forms of autoimmune hepatitis. Curr Gastroenterol Rep 1999; 1: 63–70.
  • 11
    Chapman RWG, Arborgh BAM, Rhoes JM. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980; 21: 870–877.
  • 12
    Zauli D, Schrumpf E, Crespi C. An autoantibody profile in primary sclerosing cholangitis. J Hepatol 1987; 5: 14–18.
  • 13
    Czaja AJ, Santrach PJ, Breanndan MS. Shared genetic risk factors in autoimmune liver disease. Dig Dis Sci 2001; 46: 140–147.
  • 14
    Chapman RWG. Role of immune factors in the pathogenesis of primary sclerosing cholangitis. Semin Liver Dis 1991; 11: 1–4.
  • 15
    Johnson PJ, McFarlane IG, Eddleston ALWF. The natural course and heterogeneity of autoimmune type chronic active hepatitis. Semin Liver Dis 1991; 11: 187–196.
  • 16
    Bodenheimer HC, LaRusso NA, Thayer WR. Elevated circulating immune complexes in primary sclerosing cholangitis. Hepatology 1983; 3: 150–154.
    Direct Link:
  • 17
    Whiteside TL, Lasky S, Si L, Van Thiel DH. Immunologic analyses of mononuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis. Hepatology 1985; 5: 468–474.
    Direct Link:
  • 18
    Lindor KD, Wiesner RH, Katzmann JA. Lymphocyte subsets in primary sclerosing cholangitis. Dig Dis Sci 1987; 32: 720–725.
  • 19
    Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 1998; 33: 99–103.
  • 20
    Kaya M, Angulo P, Lindor KD. Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system. J Hepatol 2000; 33: 537–542.
  • 21
    van Buuren HR, van Hoogstraten HJE, Terkivatan T, Schalm SW, Vleggaar FP. High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis. J Hepatol 2000; 33: 543–548.
  • 22
    Czaja A, Carpenter H. Autoimmune hepatitis with incidental histologic features of bile duct injury. Hepatology 2001; 34: 659–665.
    Direct Link:
  • 23
    Perdigoto R, Carpenter H, Czaja A. Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis. J Hepatol 1992; 14: 325–331.
  • 24
    Angulo P, Yaakov M-K, Lindor KD. Small-duct primary sclerosing cholangitis: a long-term follow-up study. Hepatology 2002; 35: 1494–1500.
    Direct Link:
Get PDF (743K)